ARCHIVES

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

DCBDC Board Ok’s New Initiative For Training

November 16, 1990

Most Comprehensive Centers Score High; Few May Be In Trouble; Directors Back Program

May 19, 1978

Dexamethasone Improved Survival Of Leukemia

November 26, 2004

In Brief: NIH Funding For Shannon Awards To Fall, Eight Institutes Decide Not To Participate

August 13, 1993

Breast Implants Lessen Ability Of Mammograms To Find Cancer

February 27, 2004

FDA Approves Generic Oncology Injectable Currently In Shortage

September 27, 2013